ACPCC
MONITORING, EVALUATION AND LEARNING FRAMEWORK
1. INTRODUCTION
The Australian Centre for the Prevention of Cervical Cancer (ACPCC) Monitoring, Learning and Evaluation Framework guides how the organisation tracks and assesses its progress towards strategic outcomes and the impacts of its services, programs and projects. It also describes our system for quality assurance and continuous improvement.
Our approach to monitoring and evaluation ensures we understand how and to what degree we are:
• Achieving ACPCC’s strategic goals and outcomes.
• Contributing to Victorian, Australian and global population health priorities, particularly for underserved communities.
• Impacting global strategies and frameworks such as the WHO Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem and the Sustainable Development Goals (SDGs).
• Contributing to the evidence base for vaccination, screening and population-based testing programs and technology.
• Delivering value for money and being accountable to funders, donors, partners, and recipients of our services and programs.
• Meeting our legislative and regulatory obligations.
Our quality assurance system ensures that we:
• Meet our quality objectives and relevant accreditation standards.
• Understand and act in accordance with our ethical principles and our financial and clinical governance protocols.
• Provide safe services and safe work environments.
• Regularly review our policies and procedures and staff compliance with these.
• Implement continuous quality improvement activities.
1.1. ABOUT ACPCC
VISION
To prevent cancer and infectious diseases through excellence in the provision of public health services supporting screening, populationbased testing and vaccination.
VALUES
FAIRNESS
INTEGRITY RESPECT EXCELLENCE
WHAT WE DO
Australia is a world leader in achieving cervical cancer control in our population; it will be one of the first countries to eliminate this preventable disease as a public health problem. The Australian Centre for the Prevention of Cervical Cancer extends its support and expertise to nations across the globe to help eliminate cervical cancer for all women and people with a cervix.
ACPCC is a not-for-profit, multidisciplinary team that has led cervical cancer prevention efforts in Australia for six decades. We employ that experience to strategically recommend to government those changes in the National Cervical Screening Program that are required to keep it effective and cost-effective, including renewal and self-collection.
We house and operate Australia’s HPV Reference Laboratory. We enable Australia’s aspiration to be the first country globally to eliminate cervical cancer, to meet the WHO elimination targets, and to support countries in the Indo-Pacific to reduce the incidence and mortality rates of cervical cancer.
Everything that we do is informed by the best available evidence and the interests of communities first and foremost.
We are evolving our services and projects as we move towards the target of cervical cancer elimination.
Australian Centre for the Prevention of Cervical Cancer (ACPCC) is a Company Limited by Guarantee that operates under and complies with the:
• Corporations Act 2001 (Cth)
• Australian Charities and Not-for-profits Commission Act 2012 (Cth)
• Improving Cancer Outcomes Act 2014 (Vic).
Our Population Health team provide a combination of experience in delivering and managing population health services through registry services, epidemiology, research and evaluation, health information management, reporting and statistical analysis which allows us to find the best solutions to improve health outcomes for everyone. This unique skill mix is key to our success and international reputation for high-quality, policyrelevant research focused on preventing cancer and infectious disease.
VCS Pathology is a specialist laboratory and medical education service committed to gynaecological health including HPV testing, histopathology, cytology and related molecular microbiology, clinical support and advice. We are Australia’s HPV and cervical screening reference laboratory. SARS-CoV-2 testing was introduced in 2020 to support the Victorian Government response during the pandemic.
Our team of experts work collaboratively and invest in strategic relationships with clients, government, program partners and stakeholders. We are committed to being strong and effective advocates for population health programs and have extensive experience as advisors and experts in population screening and vaccination.
Our Digital Health team are market leaders in innovative, integrated digital healthcare solutions and services that deliver improved health outcomes. Our core capabilities include population health management platforms and a broad range of IT service management expertise.
With a 25-year track record in building, integrating, deploying and supporting advanced eHealth solutions, our products and services are used by governments and researchers around the world.
ACPCC Global draws on and utilises the strengths and competencies that have been developed over 60 years in a wide range of jurisdictions. ACPCC Global now captures the myriad of international work which is undertaken across the organisation.
1.2. OUR GUIDING PRINCIPLES
Developing and using best practice and evidence-based approaches.
Working in collaboration and through partnerships to strengthen our services and programs.
Putting equity and inclusion at the forefront of all we do and recognising intersectionality.
Prioritising the health, safety and wellbeing of participants in our services and programs above other objectives.
Sharing our knowledge, expertise and learnings with partners, academic and health institutions, and the broader community for mutual benefit.
Building the capacity of our organisation, and the skills of others in the health sector locally and internationally.
Promoting freedom of choice and informed consent which reflects individual differences and preferences.
Do no harm: seek to protect the rights, health, safety, and livelihoods of people including, children, women, indigenous peoples, and other vulnerable or disadvantaged groups. Maintain the health, diversity and productivity of the environment.
1.3. ACPCC’S 5-YEAR STRATEGIC GOALS
The ACPCC Strategic Plan 2020-2025 was developed by the ACPCC Board of Directors in consultation with the Executive Team.
Over the five years of the plan, we commit to assisting the Victorian Government, the Commonwealth and countries in the Indo-Pacific region to eliminate cervical cancer as a public health issue.
We continue to support the National Bowel Cancer Screening Program through the delivery of our funded services.
We will build on laboratory service excellence by diversifying the range of VCS Pathology test capabilities and our unique position as the HPV Reference Laboratory.
1. Support Victoria’s efforts to eliminate cervical cancer as a public health problem by a target date agreed with the Department of Health, in accordance with the Victorian Cancer Plan 2020-24.
2. Support Australia’s efforts to eliminate cervical cancer as a public health problem by 2035.
3. Support countries in the Indo-Pacific region to scale up to meet the 2030 targets in support of the WHO strategy to eliminate cervical cancer as a public health problem.
4. Lead and promote the increased uptake of self-sampling.
5. Support the National Bowel Cancer Screening Program in Victoria.
6. Deliver and disseminate the research outcomes of the Compass trial, C4 and other policy relevant research.
7. Diversify the range of VCS Pathology laboratory tests by leveraging our existing expertise and capital investment.
8. Leverage the value of the canSCREEN® and canVAX platforms for cost effective support of Low to Middle Income Countries (LMICs) and for commercially advantageous opportunities.
9. Reshape the business model to adapt to our new commercial environment and global opportunities.
2. OUR APPROACH TO MONITORING, EVALUATION AND LEARNING
2.1. ORGANISATIONAL QUALITY ASSURANCE SYSTEM
Since its establishment in 1964, ACPCC has always regarded the provision of a quality service as the most important aspect of its operations. The Executive Director and staff are fully committed to the organisation being a centre of excellence in cervical screening laboratory services, related testing services and population health registry services.
The quality objectives of ACPCC include:
• To deliver the right result to the right patient in the right time frame.
• To provide high quality laboratory screening and registry services to support public health initiatives to combat cervical and other preventable cancers.
• To provide laboratory screening and testing activities to monitor infectious diseases at a public health and population level.
• To maintain the highest ethical and professional standards to always ensure patient confidentiality, whilst providing appropriate health care to our patients.
• To maintain the highest standards of Laboratory Medicine by retaining National Association of Testing Authorities (NATA) laboratory accreditation and compliance to National Pathology Accreditation Advisory Council (NPAAC) and ISO 15189 requirements.
• To conduct high quality, ethical research and health improvement projects to support our public health commitment to the prevention and early detection of cervical and other preventable cancers.
Our quality system comprises the structure, objectives and policies of ACPCC and the description of work practices and procedures that promote a high quality of operation in all aspects of our work. Thus, the quality system forms the basis on which the pathology laboratory and population health registries and services operate.
All staff embrace an ethos of quality improvement and a patient focus. We have a broad perspective of our customer base, seeing this as comprising the health practitioners who send us pathology samples for reporting, the people from whom the samples are taken and who are supported by our population health services, and our funding bodies.
As previously mentioned, ACPCC is committed to meeting all relevant industry standards, including ISO 15189 and the various requirements of NATA, NPAAC, the Royal College of Pathologists of Australasia (RCPA) and our insurers.
All staff are committed to the quality system and our Quality Team coordinates our quality assurance activities. Our commitment is not only demonstrated by the care we give to the work we do, but also by our ongoing staff training and performance management, document control, regular document review, ongoing system of internal audits, formal system for complaints, ‘opportunities for improvement’ requests and our management review program.
All staff have access to the Quality Manual and the associated policy and procedure documents and are introduced to these during their induction and training period. These are available online with some hard copies strategically distributed. The Quality Manual and the associated policy and procedure documents are formally reviewed on a two-yearly cycle as well as being updated on an ‘as needs’ basis.
Quality meetings are held monthly chaired by the Executive Director. Detailed reports are presented by senior staff responsible for quality and performance indicators. Areas for improvement are identified and any actions identified are assigned and reported. Quality reports are submitted to the ACPCC Board’s Quality Assurance Committee. Detailed reports of findings and actions are submitted to the Board on a quarterly basis.
The Board’s Audit and Finance Committee advises on and monitors organisational compliance with financial policies and strategies, financial performance, viability, sustainability and capital management.
2.2. PROJECT MONITORING AND EVALUATION APPROACH
Project Focus
ACPCC works with projects that align to our strategic goals and to which we can contribute our capability and expertise in preventing cervical cancer and other diseases. In brief, our key areas of capability and expertise include:
• HPV vaccination
• Cancer screening, in particular cervical cancer screening
• Laboratory services
• Population health program management
• Data analysis, reporting and evaluation
• Digital solutions for population health registries
• Education and training on cervical screening for medical practitioners, nurses and medical students
• Policy relevant research.
ACPCC has adopted the following criteria for initiating or selecting projects to work with:
Geographical focus – focusing on low- and middle-income countries in the Indo-Pacific region.
Women’s and girls’ health needs – countries and regions where progress against Sustainable Development Goals (SDGs) and women’s and girls’ health indicators are poor.
Effectiveness and capacity of ACPCC to make a real difference – where ACPCC has recognised experience, expertise and has built, or is able to build, a good working relationship with local partners.
Alignment – projects will be aligned with key national and international strategies.
Harmonisation – projects will be focused in areas of service gaps, avoiding duplication with other service providers.
Sustainability – projects will focus on delivering long-term sustainable development outcomes affecting lasting change for communities, including vulnerable and marginalised populations.
Inclusion and representation – of those who are vulnerable and those who are affected by the intersecting drivers of marginalisation and exclusion, including but not restricted to race, religion, ethnicity, indigeneity, disability, age, displacement, caste, gender, gender identity, sexuality, sexual orientation, poverty, class and socio-economic status. Our digital health registry, canSCREEN®, now captures disability indicators, with the aim of identifying and ultimately overcoming the challenges that people with disabilities in our global programs face when trying to access cervical screening.
Working with effective partners – focusing on working in partnership with NGOs and governments who have the capacity to deliver the project and impact long term change.
Ensuring value-for-money – focusing on efficient and cost-effective projects that make a difference.
Size – ensuring ACPCC has the resources and capacity to deliver the project and that the project presents opportunities for scalability at a national or regional level.
2.2. PROJECT MONITORING AND EVALUATION APPROACH (continued)
Alignment to Global Sustainable Development Goals
ACPCC ensures its strategic goals and activities contribute to the achievement of the United Nations Sustainable Development Goals (SDGs). Our work aligns to the following SDGs and targets:
SDG Targets
3.1 – By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births
3.4 - By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being
3.7 - By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes
3.8 - Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all
3b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
3c - Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States
How ACPCC contributes
Cervical cancer commonly affects women of childbearing age with families. ACPCC contributes to reducing cervical-cancer related illness and deaths of mothers and the associated social and economic impacts
ACPCC contributes to prevention, early detection, and earlier treatment of screen-detected cancers to reduce cancer-related deaths
ACPCC increases access to information about HPV and the importance of vaccination and cervical screening for reproductive health
ACPCC contributes to improving access to quality essential health-care services (HPV vaccination, cancer screening and treatment) for women and people with a cervix
ACPCC leads and contributes to valuable, policyrelevant research, particularly in relation to HPV vaccination and cancer screening. We also provide high-quality data to support the research community nationally and globally
ACPCC projects provide health workforce training and recruitment opportunities, including in the least developed countries and small island developing States
SDG Targets
5.1 - End all forms of discrimination against all women and girls everywhere
5.5 - Ensure women’s full and effective participation and equal opportunities for leadership at all levels of decisionmaking in political, economic and public life
5.6 - Ensure universal access to sexual and reproductive health and reproductive rights as agreed in accordance with the Programme of Action of the International Conference on Population and Development and the Beijing Platform for Action and the outcome documents of their review conferences
5.c - Adopt and strengthen sound policies and enforceable legislation for the promotion of gender equality and the empowerment of all women and girls at all levels
SDG Targets
17.3 - Mobilize additional financial resources for developing countries from multiple sources
17.6 - Enhance North-South, South-South and triangular regional and international cooperation on and access to science, technology and innovation and enhance knowledge sharing on mutually agreed terms, including through improved coordination among existing mechanisms, in particular at the United Nations level, and through a global technology facilitation mechanism
17.8 - Fully operationalize the technology bank and science, technology and innovation capacity-building mechanism for least developed countries by 2017 and enhance the use of enabling technology, in particular information and communications technology
17.9 - Enhance international support for implementing effective and targeted capacity-building in developing countries to support national plans to implement all the Sustainable Development Goals, including through NorthSouth, South-South and triangular cooperation
17.18 - By 2020, enhance capacity-building support to developing countries, including for least developed countries and small island developing States, to increase significantly the availability of high-quality, timely and reliable data disaggregated by income, gender, age, race, ethnicity, migratory status, disability, geographic location and other characteristics relevant in national contexts
How ACPCC contributes
ACPCC promotes equal rights and opportunities for girls and women everywhere through its organisational values, policies and actions
ACPCC provides equal opportunities for women to participate in meaningful work and leadership roles through its recruitment, professional development and promotion practices. We promote and support equal participation and opportunities for women in all our programs, services and projects
ACPCC’s strategic goals focus strongly on ensuring all girls and women can access HPV vaccination, cancer screening, STI testing and referral to treatment for better sexual and reproductive health outcomes
ACPCC promotes gender equality and the empowerment of women and girls through its organisational values, policies and actions
How ACPCC contributes
ACPCC’s international projects supply financial and other valued resources and support to developing countries via the funding we receive from government funders and philanthropic donors
ACPCC focuses strongly on collaborating with and sharing our research, technology and policy expertise with countries across the world in the effort to eliminate cervical cancer as a public health problem.
ACPCC supports developing countries to implement contemporary information and communications technology to manage population health programs through our canSCREEN® digital health registry
ACPCC contributes to targeted capacity building initiatives in developing countries with a direct focus on improving good health and wellbeing through vaccination and cancer screening
Through offering our canSCREEN® digital health registry to developing countries at low or no cost, ACPCC supports developing countries to collect high-quality, timely and reliable cancer screening data disaggregated by a wide range of demographic and geographic characteristics. This data supports evidence-based health decision-making
canSCREEN® and disability
Our canSCREEN® digital health registry now captures disability indicators, with the aim of identifying and ultimately overcoming the challenges that people with disabilities in our global programs face when trying to access cervical screening. These indicators were informed by the Washington Group on Disability Statistics. These challenges
may include difficulty understanding printed materials for self-collection, inaccessible healthcare facilities, and a lack of equipment that meets their needs. Communication problems and biases from healthcare providers also limit access. Furthermore, people with disabilities often face barriers like insufficient health education, transportation difficulties, and financial problems, which can delay diagnoses and worsen health outcomes.
Use of this data is supporting better programmatic decisions in these ways:
Identifying differences in screening rates
Helping develop policies that include people with disabilities
Improving healthcare facilities and make them more accessible
Providing better training for healthcare providers
By using these disability indicators, we can improve access to cervical screening and help ensure better health outcomes for people with disabilities.
Disability Identifiers
Do you have difficulty seeing, even if wearing glasses?
Do you have difficulty hearing, even if using a hearing aid(s)?
Do you have difficulty walking or climbing steps?
Do you have difficulty remembering or concentrating?
Do you have difficulty with self-care, such as washing all over or dressing?
Do you have difficulty communicating, for example understanding or being understood?
Our Approach to Project Monitoring and Evaluation
Planning and resources - ACPCC develops a monitoring and evaluation (M&E) plan for individual projects. A program logic, theory of change, evaluation questions and indicators are developed at the project initiation phase and resources are allocated in project budgets to conduct M&E activities. An example of a Program Logic is provided below.
Ethics - ACPCC staff adhere to the ethical principles articulated in our Quality Manual and Code of Conduct when undertaking M&E activities. Protecting the health and personal information of people who participate in our projects, programs and services is of paramount importance. ACPCC staff receive annual training in privacy and confidentiality requirements and are trained to handle health and personal data in accordance with relevant internal procedures and legislation. Data used for publications goes through ethics approval by an accredited ethics committee.
PROGRAM LOGIC: canSCREEN®: a proven cancer screening register
Goal To help build resilient and equitable health systems in the Pacific region, capable of progressively reducing the burden of cervical cancer and other screen-detected cancers
Strategic objective
Development / end of investment outcomes
Partner countries have high-quality data and effective patient follow-up systems in place to reduce the burden of cervical and other screen-detected cancers
Partner countries supported to better prevent and control non-communicable diseases
Strengthened cervical screening, early detection and treatment of cervical cancer (and other screen detected cancers in the future)
Cross cutting outcomes Stronger GEDSI integration and outcomes
Immediate outcomes Increase proportion of people returning for follow-up care after a HPV positive cervical screening result
Activities
Co-design a canSCREEN® implementation plan with incountry partners
Outputs Cancer screening registry established in each country
Ministry of Health staff trained to extract reports and use data
Increase community engagement with and acceptance of cervical screening
Recruit a canSCREEN® Master Trainer and Support Officer in each country
Nurses and health workers trained to collect data
Regular screening activity and outcome reports produced
Reduce the burden of cervical cancer on individuals and communities through prevention, early detection and earlier treatment
Test that canSCREEN® registry is working as expected (online and offline apps)
People screened for cervical cancer
People in whom HPV is detected are linked to follow-up care
Partner countries have improved capabilities, resources, regulatory mechanisms and systems to meet their country’s health needs
Strengthened data systems, with quality data increasingly informing evidence-based decision-making to enhance health policy and planning
Increased community engagement in cervical screening and other cancer screening programs
Strengthen skills in using data to inform health decision-making and prioritisation
Facilitate patient followup procedures and referral arrangements with local hospitals
Increase in-country knowledge of cervical cancer epidemiology and barriers to uptake of screening
Deliver training to canSCREEN® users (nurses, health workers, Ministry of Health staff)
Localised procedures for using canSCREEN® data for program planning and monitoring
People with cervical pre-cancer and cancer receive treatment
Expand use of canSCREEN® to enhance and inform other cancer screening programs e.g. breast, bowel
Local health teams collect and record patient data in canSCREEN® at the point of care
Data linkage arrangements in place between screening, vaccination, cancer registers and in-country laboratories
Program performance measures to assess shortand long-term impact of screening programs
Data collection methods - ACPCC uses quantitative and qualitative evaluation approaches. Data and evidence for M&E is captured during projects via means such as data extracts (e.g., from canSCREEN®, our laboratory information system and/or external databases), data reported by project partners and participants, case studies, interviews, periodic reviews of activities, outputs and outcomes, and evaluations.
Equity focus - ACPCC ensures data is captured, analysed and reported by as many demographic and geographic variables as possible, relevant to achieving the project outcomes. Much of our work focuses on addressing equity gaps in the incidence of screen-detectable cancers and infectious diseases. Understanding health behaviours, health service access, and health outcomes across different socioeconomic groups and locations is key to informing health programs and policies that address equity gaps.
Area of focus Evaluation questions
Continuous learning - Projects are managed with agility to allow learning to be incorporated and contribute to continuous improvement during the implementation phase.
Key Evaluation Questions - To guide project teams during the initial planning phase, ACPCC refers to the following key evaluation questions adopted.
Programs and services funded by partners such as the Australian and Victorian Departments of Health are monitored and evaluated according to agreed key performance indicators, benchmarks and regular reviews. Commonly, these indicators are defined within national and/or Victorian screening program policies, guidelines, standards, and quality frameworks. They are often also defined in funding agreements or contracts.
Relevance To what extent was the program/project in line with local needs and priorities?
Acceptability To what extent is the project/process judged as suitable and appropriate by stakeholders and beneficiaries?
Effectiveness
To what extent was the project/process successfully delivered to intended participants? Were the stated goals and objectives of the program achieved? What were the main enabling and contributing factors to any program achievements? What were the main challenges or limitations during program implementation?
Efficiency To what extent was the project/process carried out with intended participants using existing means, resources, and circumstances? What resources were required to implement? What outputs were achieved because of the inputs?
Impact
Integration/ sustainability
Shared learning
What was the impact (expected/unexpected, positive/negative) of the program for partners, clinicians, community members, and other program beneficiaries?
To what extent can the project/process be integrated within an existing system? To what extent will the program and related activities, and any achievements or change, be continued after program cessation? To what extent can the project/process be expanded?
How have we learned from the program and shared this learning?
Program Logic Elimination Partnership in the Indo-Pacific for Cervical Cancer (EPICC)
ACPCC is expanding our work - previously undertaken in parts of PNG and Vanuatu - into six more countries under DFAT’s Partnerships for a Healthy Region program. Of the six priority areas of work, ACPCC is responsible for two: provision of our digital health cancer screening registry canSCREEN®, and provision of laboratory support and strengthening. The program logic for the EPICC program is below:
Goal
Strategic objective
Partner countries in Pacific and Southeast Asia placed on path towards the elimination of cervical cancer in an equitable way
Australia is a trusted health partner in the Pacific and Southeast Asia, with stronger institutional linkages and high value placed on Development objective Pacific and Southeast Asian countries have more resilient and equitable public health systems with greater capability to eliminate Development outcomes
EOPO2: Australian assistance contributes to improved capacity of partner countries to prevent and control cervical cancer, and to make progress towards achieving cervical cancer elimination, in an inclusive, quality-assured, rights-based and equitable way
I0 2.1: Effective health promotion and policy, focused on HPV infection (major cervical cancer risk factory)
I0 2.2: Strengthened screening, early detection and management of cervical pre-cancer and cancer
IO 2.3: Effective models of care developed that are accessible and acceptable
Strategic outcome (cross-cutting)
Cross cutting outcomes
EOPO5: Australia’s regional health assistance is flexible, responsive and meets the needs of partner countries
IO 5.1: Partnerships across government and non-governmental agencies and Australian institutions support the provision of Australian health expertise into the region, to meet the needs of diverse groups of women and girls and support their access to cervical cancer care
IO 5.2: Coordinated action and policy regional and Australian partners and
IO CC2: Cervical cancer elimination programs are responsive to gender, disability and other social determinants of health, through IO CC3: Increased community engagement and active involvement in cervical cancer elimination programs, including groups who Outputs Partner countries are supposed to implement and expand inclusive and acceptable HPV vaccination programs for girls in all their diversity
(IO 2.1, 4.2, 4.4)
(IO CC2, CC3)
(IO 5.1, 5.2, 5.3)
Activities
• Technical & policy support for HPV vaccination program planning and implementation
• Assess vaccine hesitancy, barriers to access, and health system readiness
Inclusive and acceptable HPV-based cervical screening programs for women in all their diversity are implemented in selected provinces/ municipalities in PNG, Malaysia, Solomon Islands, Timor-Leste and Nauru1
(IO 2.2, 2.3, 4.3, 4.4)
(IO CC2, CC3)
(IO 5.1, 5.2, 5.3)
• Embed HPV screening and treatment programs within partner health systems
• Co-design, adopt and implement training, tools and SOPs, for clinical, laboratory and program management staff
• Develop communication resources and strategies to inform and engage clients, communities, health workers
• Generate policy relevant evidence for sustained service delivery and scale-up
• Implement advocacy strategies for cervical cancer prevention
Inputs Financial, material, human and intellectual resources detailed on the budget section
Laboratory strengthening in PNG, Malaysia, Solomon Islands, Timor-Leste, Tuvalu Nauru1 for Improved screening and (IO 2.2, 4.2, 4.3, 4.4)
(IO CC2, CC3)
(IO 5.1, 5.2, 5.3)
• Provide locally adapted laboratory, technical support and expertise
• Design and implement laboratory quality control and quality assurance frameworks and procedures
• Provide training, technical assistance, resources to strengthen data management and analysis
AW1: HPV Vaccination
AW2: HPV Screen-and-Treat
AW3: Laboratory Strengthening
our public health expertise cervical cancer
EOPO4: Australian assistance contributes to partner countries’ improved regulatory mechanisms, data systems, and capabilities to deliver inclusive, quality, rights-based and equitable cervical cancer care
IO 4.2: Strengthened data systems to enhance evidence-based health policy and programming
policy dialogue for cervical cancer elimination across global, and with posts
stronger GEDSI integration and outcomes
experience social disadvantage
Malaysia, Tuvalu and diagnosis
training, quality frameworks assistance, and management
canSCREEN® electronic registry locallyadapted and implemented in Solomon Islands, Timor-Leste, Tuvalu and expanded its utilisation in PNG and Malaysia
(IO 2.2, 2.3,, 4.2))
(IO CC2, CC3)
(IO 5.1, 5.2, 5.3)
• Adapt canSCREEN® with country partners and tailor to locally specific language, geographic, health systems, and treatment pathway requirements
• Co-design, adapt and implement training, SOPs and data quality framework
• Provide essential infrastructure and hardware
• Conduct user acceptance testing
• Implement canSCREEN®
IO 4.3: Workforce skills enhanced equitably across key areas, addressing partner government priorities
IO 5.3: Efficient program delivery
IO 4.4: Robust evidence-based guidance for policy and clinical practice development provided to in-country partners and stakeholders
Cervical cancer management strengthened in all partner countries to meet the needs of diverse groups of people with cervical cancer, include those from social disadvantage groups
(IO 2.2, 4.3, 4.4)
(IO CC2, CC3)
(IO 5.1, 5.2, 5.3)
• Training fellowships in gynae-oncology (Fiji and PNG) and remote MDT support
• Palliative care training programs (PNG, Fiji, Solomon Islands, Timor, Vanuatu)
• Maturity assessment and local guides for cervical cancer management (PNG, Fiji, Solomon Islands and Timor)
• Establish South-Pacific Cancer Control Coalition
• Optimise local/regional referral pathways
• Implement advocacy strategies for cervical cancer management
Policy, modelling and advocacy support in all partner countries for HPV vaccination, cervical screening and management of cervical precancer and cancer
(IO 2.1, 4.2, 4.3, 4.4)
(IO CC2, CC3)
(IO 5.1, 5.2, 5.3)
• Use of Policy1-Cervix modelling platform and other tools to evaluate strategies and models for HPV vaccination, screening and treatment in partner countries
• Build solid investment cases for sustainability of the programmes
• Improve advocacy strategies for cervical cancer elimination, through CSO strengthening, health literacy and empowerment of women, including those from disadvantaged groups
• Support CS representatives improving knowledge and leadership skills, through the UICC Cancer Advocates Programme ELIMINATION
AW4: Digital Health Registries
AW5: Management Cervical Cancer
AW6: Policy and Modelling
2.3.
SHARED LEARNING
ACPCC places a strong emphasis on continuous improvement within our organisation and on sharing our learning with partners, government bodies, academic institutions and the broader health sector for the benefit of the community. We use a range of methods to create and exchange knowledge and to reflect on good practice and lessons learned.
LEARNING
Training and professional development opportunities
Monitoring and evaluation of programs, services and projects
Translating research and project outcomes into service and program improvements
Staff meetings in large and small groups
Audits of policies and procedures
Observation of and reflection about our own activities and those of others in our sector
Seeking feedback from stakeholders and partners
Staff surveys
Creating or updating best practice guides
‘Opportunities for improvement’ requests
SHARING
ACPCC website
Project reports
Journal publications
Hosting conferences
Conference/seminar presentations
ACPCC education modules and webinars for health practitioners
ECHO networks
E-newsletters
Social media
Contributing to committees and other forums
ACKNOWLEDGEMENTS
ACPCC thanks and acknowledges our valued C4 partner Family Planning Australia for sharing its approach to Monitoring, Learning and Evaluation with us. Sections of this document have been adopted or adapted from FPA’s Development Effectiveness Framework.
CONTACT US
Feedback and queries are welcome. Please contact A/Prof Misha Coleman, ODA Expertise Lead mcoleman@acpcc.org.au
